What is Budesonide - Global Market?
Budesonide is a corticosteroid that is used globally for a variety of medical treatments. It's a medication that is primarily used to treat asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Additionally, it is used for inflammatory bowel disease. It is available in various forms such as injectable suspension, aerosols, inhalation powder, tablet, and capsule. The global market for Budesonide is vast and continues to grow as the need for these treatments increases.
Injectable Suspension, Aerosols, Inhalation Powder, Tablet and Capsule in the Budesonide - Global Market:
The different forms of Budesonide, including injectable suspension, aerosols, inhalation powder, tablet, and capsule, each have their own unique market within the global Budesonide market. The injectable suspension is often used for severe asthma cases, while the aerosols and inhalation powder are commonly used for regular asthma treatment and prevention. The tablet and capsule forms are typically used for the treatment of inflammatory bowel diseases. Each of these forms has its own market share and growth rate within the global Budesonide market, contributing to the overall growth of this market.
Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Others in the Budesonide - Global Market:
Budesonide is used globally in various areas of treatment. It plays a significant role in the treatment of respiratory diseases, particularly asthma. It helps to reduce inflammation and swelling in the airways, making breathing easier. In the treatment of nose diseases, Budesonide is used to reduce symptoms such as runny nose, sneezing, and itching caused by seasonal allergies or hay fever. It is also used in the treatment of inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, to reduce pain and discomfort. Other uses of Budesonide include the treatment of certain types of arthritis, skin conditions, and autoimmune diseases.
Budesonide - Global Market Outlook:
The global Budesonide market is a robust and growing industry. In 2022, the market was valued at US$ 8203 million and is projected to reach US$ 10250 million by 2029. This represents a compound annual growth rate (CAGR) of 3.2% during the forecast period from 2023 to 2029. North America holds the largest share of the market, accounting for about 36% of the total revenue. The largest manufacturer of Budesonide is AstraZeneca, which holds about 56% of the total revenue market share.
| Report Metric | Details |
| Report Name | Budesonide - Market |
| Forecasted market size in 2029 | US$ 10250 million |
| CAGR | 3.2% |
| Forecasted years | 2023 - 2029 |
| Global Budesonide market, by region: |
|
| Global Budesonide market, Segment by Type: |
|
| Global Budesonide market, by Application |
|
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
